# tSCS and 5-Azacitidine for Enhanced Motor Outcomes in Cerebral Palsy

> **NCT07433023** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Shirley Ryan AbilityLab** · enrollment: 80 (estimated)

## Conditions studied

- Cerebral Palsy

## Interventions

- **OTHER:** tSCS
- **DRUG:** 5-Azacitidine
- **DRUG:** Mannitol
- **OTHER:** Functional Activity Training

## Key facts

- **NCT ID:** NCT07433023
- **Lead sponsor:** Shirley Ryan AbilityLab
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2029-01-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07433023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07433023, "tSCS and 5-Azacitidine for Enhanced Motor Outcomes in Cerebral Palsy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07433023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*